Vicor's Licensing Royalties: A Bullish Narrative That Still Needs Proof

What happened

A Zacks article highlights Vicor's expanding licensing strategy as a potential source of recurring royalty income, driven by AI power demand. The DeepValue master report acknowledges this but stresses that royalties are lumpy and recognized based on licensee sales, not Vicor's shipments. While the May 2026 guidance raise included 'additional royalties,' the report warns that valuation is extreme at 120.6x P/E and the backlog conversion is uncertain. The licensing story is a core pillar of the bull case, but execution and repeatability remain unproven at these prices.

Implication

The licensing narrative supports the bull case but does not change the WAIT rating. Investors should monitor Q2 2026 results for royalty sustainability and backlog conversion. Without evidence of recurring royalty streams, the current valuation leaves no margin for error. The thesis hinges on execution: if royalties prove repeatable, it could justify a higher valuation; if not, downside risk is significant.

Thesis delta

No material shift. The existing thesis already incorporates licensing as a key upside driver, but the news reinforces the need to underwrite royalty repeatability rather than assume it. The WAIT rating remains appropriate until Q2 2026 confirms sustainable royalties and backlog conversion.